Abstract
Cerebral blood flow (CBF), oxygen metabolism (CMRO2), and glucose metabolism (CMRGlc) were measure using positron emission tomography in five patients diagnosed as having mitochondrial encephalomyopathy. The molar ratio between the oxygen and glucose consumptions was reduced diffusely, as CMRO2 was markedly decreased and CMRGlc was slightly reduced. The CBF showed less changes. The CBF increase on hypercapnia was smaller than normal, though this was not significant. CBF with hypocapnia demonstrated a significant reduction compared with the normal. These results suggest that oxidative metabolism is imparied and anaerobic glycolysis relatively stimulated, due to a primary defect of mitochondrial function, and that mild lactic acidosis occurs in brain tissue because of impaired utilisation of pyruvate in the TCA cycle. As these findings appear to indicate directly a characteristic of this disease, such measurements may be a useful tool for assessment of the pathophysiology and for diagnosis of mitochondrial encephalomyopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
DiMauro S, Bonilla E, Zeviani M, Nakagawa M, De Vivo DC (1985) Mitochondrial myopathies. Ann Neurol 17:521–538
Kanno I, Miura S, Yamamoto S, Iida H, Murakami M, Takahashi K, Uemura K (1985) Design and evaluation of a positron emission tomograph: HEAD-TOME III. J Comput Assist Tomogr 9: 931–939
Shishido F, Uemura K, Inugami A, Ogawa T, Yamaguchi T, Kanno I, Murakami M, Tagawa K, Yasui N (1987) Remote effects in MCA teritory ischemic infarction: a study of regional cerebral blood flow and oxygen metabolism using positron emission tomography and15O labeled gases. Radiat Med 5:36–41
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local glucose metabolic rate in humans with [F-18]2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6:371–388
Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C, MacGregor RR, Shiue CY, Atkins H, Anand A, Dann R, Greenberg JH (1985) Glucose metabolic rate kinetic model parameter determination in human: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metabol 5:179–192
Kanno I, Iida H, Miura S, Murakami M, Takahashi K, Sasaki H, Inugami A, Shishido F, Uemura K (1987) A system for cerebral blood flow measurement using an H2 15O autoradiographic method and positron emission tomography. J Cereb Blood Flow Metabol 7:143–153
Kety SS (1956) Human cerebral blood flow and oxygen consumption as related to aging. Res Publ Assoc Nerv Ment Dis 35:31–45
Frackowiak RSJ, Herold S, Petty RKH, Morgan-Hughes JA (1988) The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases. Brain 111:1009–1024
De Volder A, Ghilain S, Barsy T de, Goffinet AM (1988) Brain metabolism in mitochondrial encephalomyopathy: a PET study. J Comput Assist Tomogr 12: 854–857
Berkovic S, Carpenter S, Evans A, Karpati G, Shoubridge EA, Andermann F, Meyer E, Tyler JL, Diksic M, Arnold D, Wolfe LS, Andermann E, Hakim AM (1989) Myoclonus epilepsy and raggedred fibers (MERRF): a clinical, pathological, biochemical, magnetic resonance spectroscopic, and positron emission tomographic study with a new hypothesis for the pathogenesis of mitochondrial encephalopathies. Brain 112:1231–1260
Matthews PM, Berkovic SF, Shoubridge EA, Andermann F, Karpati G, Carpenter S, Arnold D (1991) In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF). Ann Neurol 29:435–438
Eleff SM, Barker PB, Blackband SJ, Chatham JC, Lutz NW, Johns DR, Bryan RN, Hurko O (1990) Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol 27:626–630
Toyoda M, Arai S, Sakuragawa N, Hara T, Iio M (1988) Positron emission tomography using pyruvate-1-11C on mitochondrial encephalomyopathy. Brain Nerve 40:267–272
Matthews PM, Tampieri D, Berkovic SF, Andermann F, Silver K, Chityat D, Arnold DL (1991) Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 41: 1043–1046
Allard JC, Tilak S, Carter AP (1988) CT and MR of MELAS syndrome. AJNR 9:1234–1238
Yamamoto T, Beppu H, Tsubaki T (1984) Mitochondrial encephalomyopathy: fluctuating symptoms and CT. Neurology 34:1456–1460
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shishido, F., Uemura, K., Inugami, A. et al. Cerebral oxygen and glucose metabolism and blood flow in mitochondrial encephalomyopathy: a PET study. Neuroradiology 38, 102–107 (1996). https://doi.org/10.1007/BF00604789
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00604789